Search

everythinglearnresearchcommunity

for

Search:↓

Premature hair graying may be a sign of increased risk for heart disease, indicating biological age is more important than actual age.

High prolactin levels might be linked to hair loss in autoimmune thyroid disease, but more research is needed.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Doctors should check for serious tumor causes of high androgen levels in postmenopausal women and more research is needed on this condition.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

A specific gene change plus an additional mutation in the same gene cause hereditary trichilemmal cysts.

Researchers found two new genetic variants linked to Alzheimer's disease.

Hair loss is common in IBD patients, and some medications may lower the risk.

A genetic variant in the androgen receptor gene increases heart disease risk in women but not in men.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

The document concludes that the discussed biological mechanisms and potential therapies are not related to hair loss or hair growth.

PCOS may be linked to gum disease, but more research is needed to confirm this.

Scientists used stem cells to create a model of the skin disease Epidermolysis Bullosa simplex, which helped them understand its molecular mechanisms and could aid in finding treatments.

The arrector pili muscle plays a key role in hair loss in androgenetic alopecia.

DHT may increase the risk of heart disease and death in elderly men.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Skin can produce blood cells, often due to disease, which might lead to new treatments for skin and blood conditions.

Male hormones may make COVID-19 worse, while substances that block these hormones could lessen symptoms.

Melanocytes are important for normal body functions and have potential uses in regenerative medicine and disease treatment.

Sex hormones may affect COVID-19 severity and outcomes.

Premature aging increases the risk of immune problems and autoimmune diseases.

Finasteride may reduce prostate bleeding by lowering blood vessel growth factor levels and blood vessel density in certain prostate areas.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Testosterone is linked to cardiovascular risk factors and stroke, but its exact role is unclear.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.